Tirz / Sema Combo

This is a custom research blend of 10mg Tirzepatide and 2mg Semaglutide. 

Both Tirzepatide and Semaglutide are powerful peptide-based medications that mimic incretin hormones involved in glucose regulation and appetite control. While each is highly effective on its own, combining the two may produce enhanced metabolic outcomes for select individuals—though it must be done with extreme care and clinical supervision due to overlapping mechanisms and potential side effects.

Semaglutide

• A GLP-1 receptor agonist, it mimics the effects of the glucagon-like peptide-1 hormone.
• Increases insulin secretion in response to glucose.
• Suppresses glucagon release.
• Slows gastric emptying.
• Reduces appetite and cravings.

Tirzepatide

• A dual GIP and GLP-1 receptor agonist.
• Activates both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors.
• Improves insulin sensitivity more than GLP-1 alone.
• Provides stronger reductions in HbA1c and body weight in trials compared to Semaglutide alone.